Incidence of Breast Cancer in Fars Province, Southern Iran: a Hospital-based Study

Overview

Journal World J Plast Surg

Specialty General Surgery

Date 2015 Mar 4

PMID 25734039

Citations 11

Authors

Davood Mehrabani

Amir Almasi

Mahin Farahmand

Z Ahrari

Abbas Rezaianzadeh

Golnoush Mehrabani

Abdol Rasoul Talei

Affiliations

Soon will be listed here.

Abstract

Background: Breast cancer is still considered as one of the most common female cancers worldwide regardless of the countries' level of development. This study determines the incidence of breast cancer in Fars Province, Southern Iran.

Methods: This study used patients' records from Shiraz University of Medical Sciences Cancer Registry Centre, which is a Hospital-Based Registry of Nemazee Hospital. Data were recorded based on International Classification of Diseases for Oncology (ICD-O) and compromised all invasive cancers in ICD-10 categories of C-00 to C-80. The findings were shown as the number of cases by site (ICD-10) and gender, with crude incidence (CRs), age-specific incidence and age-standardized incidence rates (ASRs) per 100,000 persons per year, performed by direct method using the world standard population.

Results: The age group of 40-49 years had the highest rate of breast cancer and naturally most cases were post-menopause ones. Most cases were diagnosed in moderate differentiated state with an increasing trend. Early diagnosis of in situ neoplasms has not increased over time in comprised with malignant cases. The number of diagnosed cases has sharply increased after year 2004 especially during post-menopause period.

Conclusion: As the number of diagnosed cases has increased during post-menopausal period, screening and health programs seem necessary for menopause women.

Citing Articles

Breast Cancer Incidence Trends in Isfahan Province Compared with those in England over the Period 2001-2013.

Ainvand M, Shakibaei N, Ravankhah Z, Yadegarfar G Int J Prev Med. 2021; 12:54.

PMID: 34447496 PMC: 8356948. DOI: 10.4103/ijpvm.IJPVM_360_19.

Breast Reconstruction after Mastectomy in Women with Breast Cancer: A Systematic and Meta-Analysis Review.

Anbiyaiee A, Abouali Galeh Dari M, Anbiyaee O, Anbiyaiee A World J Plast Surg. 2020; 9(1):3-9.

PMID: 32190584 PMC: 7068191. DOI: 10.29252/wjps.9.1.3.

Incidence trend of breast Cancer in women of eastern Mediterranean region countries from 1998 to 2019: A systematic review and meta-analysis.

Zahedi R, Molavi Vardanjani H, Baneshi M, Haghdoost A, Malekpour Afshar R, Sarabi R BMC Womens Health. 2020; 20(1):53.

PMID: 32183824 PMC: 7079343. DOI: 10.1186/s12905-020-00903-z.

Polymorphisms in Phase I (CYP450) Genes (rs4646421), (rs1056836), (rs749292) and (rs1058930) and Their Relation to Risk of Breast Cancer: A Case-Control Study in Mazandaran Province in North of Iran.

Golmohammadzadeh G, Mohammadpour A, Ahangar N, Shokrzadeh M Open Access Maced J Med Sci. 2019; 7(15):2488-2496.

PMID: 31666853 PMC: 6814470. DOI: 10.3889/oamjms.2019.667.

New 5-D Coding System for Categorization of Plastic Surgery Conditions.

Gupta S, Chittoria R, Chavan V, Aggarwal A, Reddy C, Mohan P World J Plast Surg. 2019; 8(3):388-393.

PMID: 31620343 PMC: 6790266. DOI: 10.29252/wjps.8.3.388.

References

Heiss G, Wallace R, Anderson G, Aragaki A, Beresford S, Brzyski R . Health risks and benefits 3 years after stopping randomized treatment with estrogen and progestin. JAMA. 2008; 299(9):1036-45. DOI: 10.1001/jama.299.9.1036. View

Sadjadi A, Nouraie M, Mohagheghi M, Mousavi-Jarrahi A, Malekezadeh R, Parkin D . Cancer occurrence in Iran in 2002, an international perspective. Asian Pac J Cancer Prev. 2005; 6(3):359-63. View

. Breast cancer and hormone replacement therapy: collaborative reanalysis of data from 51 epidemiological studies of 52,705 women with breast cancer and 108,411 women without breast cancer. Collaborative Group on Hormonal Factors in Breast Cancer. Lancet. 1999; 350(9084):1047-59. View

Levi F, Lucchini F, Negri E, La Vecchia C . Continuing declines in cancer mortality in the European Union. Ann Oncol. 2006; 18(3):593-5. DOI: 10.1093/annonc/mdl437. View

McPherson K, Steel C, Dixon J . ABC of breast diseases. Breast cancer-epidemiology, risk factors, and genetics. BMJ. 2000; 321(7261):624-8. PMC: 1118507. DOI: 10.1136/bmj.321.7261.624. View

Harirchi I, Karbakhsh M, Montazeri A, Ebrahimi M, Jarvandi S, Zamani N . Decreasing trend of tumor size and downstaging in breast cancer in Iran: results of a 15-year study. Eur J Cancer Prev. 2009; 19(2):126-30. DOI: 10.1097/CEJ.0b013e328333d0b3. View

Harirchi I, Ebrahimi M, Zamani N, Jarvandi S, Montazeri A . Breast cancer in Iran: a review of 903 case records. Public Health. 2000; 114(2):143-5. DOI: 10.1038/sj.ph.1900623. View

Ess S, Savidan A, Frick H, Rageth C, Vlastos G, Lutolf U . Geographic variation in breast cancer care in Switzerland. Cancer Epidemiol. 2010; 34(2):116-21. DOI: 10.1016/j.canep.2010.01.008. View

Ursin G, Ross R, Sullivan-Halley J, Hanisch R, Henderson B, Bernstein L . Use of oral contraceptives and risk of breast cancer in young women. Breast Cancer Res Treat. 1998; 50(2):175-84. DOI: 10.1023/a:1006037823178. View

10.

Sadjadi A, Malekzadeh R, Derakhshan M, Sepehr A, Nouraie M, Sotoudeh M . Cancer occurrence in Ardabil: results of a population-based cancer registry from Iran. Int J Cancer. 2003; 107(1):113-8. DOI: 10.1002/ijc.11359. View

11.

Mousavi S, Gouya M, Ramazani R, Davanlou M, Hajsadeghi N, Seddighi Z . Cancer incidence and mortality in Iran. Ann Oncol. 2008; 20(3):556-63. DOI: 10.1093/annonc/mdn642. View

12.

Mousavi S, Harirchi I, Ebrahimi M, Mohagheghi M, Montazeri A, Mousavi Jarrahi A . Screening for breast cancer in Iran: a challenge for health policy makers. Breast J. 2008; 14(6):605-6. DOI: 10.1111/j.1524-4741.2008.00662.x. View

13.

Wrensch M, Chew T, Farren G, Barlow J, Belli F, Clarke C . Risk factors for breast cancer in a population with high incidence rates. Breast Cancer Res. 2003; 5(4):R88-102. PMC: 165017. DOI: 10.1186/bcr605. View

14.

Farooq S, Coleman M . Breast cancer survival in South Asian women in England and Wales. J Epidemiol Community Health. 2005; 59(5):402-6. PMC: 1733081. DOI: 10.1136/jech.2004.030965. View

15.

Mahouri K, Dehghani Zahedani M, Zare S . Breast cancer risk factors in south of Islamic Republic of Iran: a case-control study. East Mediterr Health J. 2008; 13(6):1265-73. DOI: 10.26719/2007.13.6.1265. View

16.

Rezaianzadeh A, Peacock J, Reidpath D, Talei A, Hosseini S, Mehrabani D . Survival analysis of 1148 women diagnosed with breast cancer in Southern Iran. BMC Cancer. 2009; 9:168. PMC: 2699348. DOI: 10.1186/1471-2407-9-168. View

17.

Harirchi I, Karbakhsh M, Kashefi A, Momtahen A . Breast cancer in Iran: results of a multi-center study. Asian Pac J Cancer Prev. 2004; 5(1):24-7. View

18.

Jung K, Park S, Kong H, Won Y, Boo Y, Shin H . Cancer statistics in Korea: incidence, mortality and survival in 2006-2007. J Korean Med Sci. 2010; 25(8):1113-21. PMC: 2908777. DOI: 10.3346/jkms.2010.25.8.1113. View

19.

Shibuya K, Mathers C, Boschi-Pinto C, Lopez A, Murray C . Global and regional estimates of cancer mortality and incidence by site: II. Results for the global burden of disease 2000. BMC Cancer. 2002; 2:37. PMC: 149364. DOI: 10.1186/1471-2407-2-37. View

20.

Bosetti C, Bertuccio P, Levi F, Chatenoud L, Negri E, La Vecchia C . The decline in breast cancer mortality in Europe: an update (to 2009). Breast. 2011; 21(1):77-82. DOI: 10.1016/j.breast.2011.08.001. View